GABRE Gene

GABRE Gene

Overview

The GABRE gene (Gamma-Aminobutyric Acid Type A Receptor Epsilon Subunit) encodes the epsilon subunit of the GABA-A receptor, a critical ligand-gated chloride channel that mediates fast inhibitory neurotransmission in the central nervous system. Located on chromosome Xq28, the GABRE gene produces a protein that assembles with other subunits (alpha, beta, gamma) to form functional GABA-A receptors with distinct pharmacological and physiological properties[@whiting2003].

The epsilon subunit is one of the less common GABA-A receptor subunits, conferring unique characteristics including enhanced agonist sensitivity, altered desensitization kinetics, and resistance to certain allosteric modulators. GABRE is expressed in specific brain regions and peripheral tissues, where it contributes to inhibitory signaling that regulates neuronal excitability, network synchronization, and various neurological functions[@sieghart2012].

GABRE Gene

Overview

The GABRE gene (Gamma-Aminobutyric Acid Type A Receptor Epsilon Subunit) encodes the epsilon subunit of the GABA-A receptor, a critical ligand-gated chloride channel that mediates fast inhibitory neurotransmission in the central nervous system. Located on chromosome Xq28, the GABRE gene produces a protein that assembles with other subunits (alpha, beta, gamma) to form functional GABA-A receptors with distinct pharmacological and physiological properties[@whiting2003].

The epsilon subunit is one of the less common GABA-A receptor subunits, conferring unique characteristics including enhanced agonist sensitivity, altered desensitization kinetics, and resistance to certain allosteric modulators. GABRE is expressed in specific brain regions and peripheral tissues, where it contributes to inhibitory signaling that regulates neuronal excitability, network synchronization, and various neurological functions[@sieghart2012].

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:11em;">GABRE Gene</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>GABRE</td></tr>
<tr><td><strong>Full Name</strong></td><td>GABA-A Receptor Epsilon Subunit</td></tr>
<tr><td><strong>Chromosome</strong></td><td>Xq28</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[2564](https://www.ncbi.nlm.nih.gov/gene/2564)</td></tr>
<tr><td><strong>OMIM</strong></td><td>[300090](https://www.omim.org/entry/300090)</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>[ENSG00000111640](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000111640)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P18507](https://www.uniprot.org/uniprot/P18507)</td></tr>
<tr><td><strong>Protein Length</strong></td><td>506 amino acids</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>~56 kDa</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Epilepsy, Angelman syndrome, Parkinson's disease, Alzheimer's disease</td></tr>
</table>
</div>

Gene Structure and Expression

Genomic Organization

The GABRE gene spans approximately 9 kb on the long arm of the X chromosome (Xq28) and consists of 12 exons. The gene is part of a cluster of GABA-A receptor subunit genes on Xq28, including GABRA3 and GABRQ. This genomic organization reflects the evolutionary duplication of ancestral GABA-A receptor genes.

Expression Pattern

GABRE exhibits a distinct expression pattern compared to other GABA-A receptor subunits:

Brain Regions:

• Hippocampus: High expression in CA1-CA3 regions and dentate gyrus
• Cortex: Moderate expression, particularly in layer V pyramidal neurons
• Thalamus: Abundant expression in thalamic relay nuclei
• Hypothalamus: Present in various hypothalamic nuclei
• Brainstem: Expression in pontine nuclei and medulla
• Cerebellum: Lower expression in Purkinje cells and granule cells

• Heart (cardiac myocytes)
• Skeletal muscle
• Lung
• Adrenal gland
• Placenta

Cellular Localization

• Primarily postsynaptic
• Localized to synaptic and extrasynaptic membranes
• Can form both synaptic and extrasynaptic receptors

Receptor Structure and Function

GABA-A Receptor Architecture

GABA-A receptors are pentameric ligand-gated chloride channels composed of five subunits selected from 19 possible subunits (α1-6, β1-3, γ1-3, δ, ε, π, θ, ρ1-3). The most common configuration contains two α subunits, two β subunits, and one γ or δ subunit.

Epsilon-containing receptors (αβε):

• Typically contain α4, α6, or α1 subunits in combination with β2/3 and ε
• Form receptors with distinctive properties
• Often located extrasynaptically

Subunit Composition

GABRE typically assembles with:

• α4 subunits: Extrasynaptic receptors with tonic currents
• β2/3 subunits: Common partner subunits
• γ2 subunits: Synaptic localization

Molecular Function

Ion Channel Physiology

GABRE-containing receptors mediate:

Pharmacological Properties

Epsilon-containing receptors have unique pharmacological characteristics:

• Benzodiazepine sensitivity: Variable; depends on α subunit composition
• Etomidate sensitivity: Different from α1-containing receptors
• Zinc inhibition: Reduced zinc modulation compared to δ-containing receptors
• Allopregnanolone sensitivity: Enhanced modulation by neurosteroids

Signaling Pathways

GABA-A receptor activation affects:

• GABAergic signaling: Primary inhibitory neurotransmitter system
• Network oscillations: Important for rhythm generation
• Plasticity processes: GABAergic plasticity affects learning and memory

Receptor Physiology

Channel Properties

GABRE-containing receptors exhibit distinctive ion channel behavior:

Chloride Homeostasis

GABRE plays critical roles in neuronal chloride regulation:

• During development, GABA is excitatory due to high intracellular Cl-
• GABRE-containing receptors help establish the developmental switch
• In mature neurons, GABRE maintains inhibitory tone
• Dysregulation contributes to hyperexcitability

Tonic vs. Phasic Inhibition

Epsilon-containing receptors contribute to both forms of inhibition:

Phasic inhibition (synaptic):

• Fast, brief IPSCs mediated by synaptic GABA-A receptors
• GABRE can contribute to synaptic receptors in some contexts
• Critical for precise temporal inhibition

• Persistent conductance mediated by extrasynaptic receptors
• GABRE-containing receptors generate sustained tonic currents
• Modulates neuronal excitability and network gain

Allosteric Modulation

GABRE-containing receptors are modulated by multiple agents:

Role in Disease

Epilepsy

GABRE mutations are associated with epilepsy phenotypes[@macdonald2010][@lagrange2014]:

1. Genetic Epilepsy Syndromes

• Early infantile epileptic encephalopathy (EIEE)
• Dravet syndrome-like phenotypes
• Generalized epilepsy with febrile seizures plus (GEFS+)

• Loss-of-function mutations reduce inhibitory currents
• Hyperexcitability due to impaired inhibition
• Network synchronization abnormalities

• Benzodiazepine responsiveness varies
• Some mutations respond to specific antiseizure medications
• Gene therapy approaches under investigation

Parkinson's Disease

GABAergic dysfunction is central to PD pathophysiology[@mohan2019][@hernandez2018][@olson2019]:

1. Basal Ganglia Circuitry

• Increased GABAergic output from GPi/SNr contributes to bradykinesia
• Altered GABRE expression affects inhibitory signaling
• Subthalamic nucleus hyperactivity involves GABAergic mechanisms

• Loss of dopaminergic input alters GABAergic interneuron function
• GABRE expression changes in the substantia nigra and striatum
• Motor cortex hyperexcitability involves GABAergic dysregulation

• GABA-A receptor modulators used adjunctively
• Deep brain stimulation affects GABAergic circuits
• Novel GABRE-targeted therapies under investigation

Alzheimer's Disease

GABAergic signaling is altered in AD[@koson2019][@iwai2019]:

1. GABAergic Loss

• Reduced GABAergic neuron numbers in hippocampus and cortex
• Decreased GABRE expression in AD brains
• Impaired inhibitory control contributes to network dysfunction

• Aβ affects GABAergic receptor function
• Tau pathology disrupts GABAergic signaling
• Synaptic inhibition impaired before cognitive symptoms

• Hyperexcitability and seizures in AD
• Disrupted gamma oscillations
• Impaired hippocampal-cortical communication

Angelman Syndrome

GABRE is implicated in Angelman syndrome due to its location on Xq28:

• May contribute to the phenotype when other genes are affected
• GABAergic dysfunction contributes to characteristic features

Neurodevelopmental Disorders

GABRE mutations have been associated with several neurodevelopmental conditions:

Migraine

GABRE may play a role in migraine pathophysiology:

• GABAergic modulation of trigeminal pain pathways
• Cortical spreading depression mechanisms
• Genetic associations with migraine susceptibility

Sleep Disorders

GABRE influences sleep through:

• Sleep spindle generation
• NREM to REM transitions
• Sleep homeostasis mechanisms

Cellular and Molecular Mechanisms

Receptor Trafficking and Localization

GABRE-containing receptors undergo complex trafficking:

Phosphorylation Regulation

GABRE function is modulated by phosphorylation:

• PKC phosphorylation: Modulates receptor trafficking and function
• PKA phosphorylation: Affects desensitization kinetics
• Tyrosine phosphorylation: Alters channel properties
• Casein kinase 2: Constitutive phosphorylation affects localization

Protein-Protein Interactions

GABRE interacts with multiple proteins:

| Partner | Interaction | Functional Role |
|---------|------------|-----------------|
| Gephyrin | Postsynaptic scaffold | Synaptic clustering |
| Collybistin | Membrane protein | Gephyrin recruitment |
| Radixin | Cytoskeletal | Receptor anchoring |
| HAP1 | Huntingtin-associated | Trafficking regulation |
| AP2 | Clathrin adaptor | Endocytosis |

Alternative Splicing

GABRE undergoes alternative splicing:

• Exon 9 splicing affects channel properties
• Alternative 5' UTRs regulate translation
• Different isoforms in development vs. adulthood

Therapeutic Considerations

Drug Development

GABRE is a target for drug development:

Pharmacogenetics

GABRE polymorphisms affect drug responses:

• Benzodiazepine sensitivity varies with GABRE genotype
• Side effect profiles differ based on receptor composition
• Dosing considerations for certain antiepileptic drugs

Resistance Mechanisms

Epilepsy treatment resistance may involve GABRE:

• Mutations causing drug-resistant epilepsy
• Downregulation of GABRE expression
• Receptor internalization changes

Research Tools and Models

Animal Models

Key models for studying GABRE:

In Vitro Systems

Cellular models for GABRE research:

Imaging Approaches

Visualizing GABRE function:

Cross-References

• [GABA-A Receptor](/proteins/gaba-a-receptor)
• [GABA Signaling Pathway](/mechanisms/gaba-signaling)
• [Epilepsy](/diseases/epilepsy)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Basal Ganglia](/brain-regions/basalganglia)
• [Hippocampus](/brain-regions/hippocampus)

Additional Disease Associations

Rett Syndrome

GABRE dysfunction may contribute to Rett syndrome pathophysiology:

• MeCP2 regulates GABRE expression
• GABAergic deficits in Rett models
• Therapeutic implications for GABAergic agents

Down Syndrome

GABRE alterations in Down syndrome:

• Chromosome 21 localization affects expression
• GABAergic dysfunction in DS brain
• Intersection with AD-like pathology

Alcohol Use Disorder

GABRE mediates ethanol effects:

• Acute ethanol potentiation of GABRE currents
• Chronic exposure leads to receptor adaptations
• Withdrawal and anxiety mechanisms
• Genetic variants affect alcohol sensitivity

Post-Traumatic Stress Disorder

GABRE in stress response:

• GABAergic modulation of fear circuits
• Stress-induced GABRE changes
• Targeting GABRE for PTSD treatment

Genetic Considerations

Population Genetics

GABRE polymorphisms in populations:

• African, European, Asian haplotype structures
• Variable frequency of epilepsy-associated variants
• Linkage with nearby GABA-A receptor genes

Epigenetic Regulation

GABRE expression is epigenetically controlled:

• DNA methylation in disease states
• Histone modifications at GABRE locus
• Non-coding RNA regulation (miRNAs, lncRNAs)

Future Directions

Emerging Research Areas

Knowledge Gaps

Remaining questions about GABRE:

• Specific neuronal populations expressing GABRE
• Developmental regulation of ε-containing receptors
• Role in specific neural circuits
• Therapeutic targeting strategies

References

See Also

• [GABAergic Neurotransmission](/mechanisms/gaba-neurotransmission)
• [Inhibitory Synapses](/mechanisms/inhibitory-synapses)
• [GABA Receptor Subunits](/genes/gaba-receptor-subunits)
• [Network Oscillations](/mechanisms/network-oscillations)
• [Neuroinflammation](/mechanisms/neuroinflammation)

External Links

• [NCBI Gene: GABRE](https://www.ncbi.nlm.nih.gov/gene/2564)
• [UniProt: P18507](https://www.uniprot.org/uniprot/P18507)
• [OMIM: 300090](https://www.omim.org/entry/300090)
• [IUPHAR: GABA-A Receptor Database](https://www.guidetopharmacology.org/GRAC/ReceptorFamilies)
• [GeneCards: GABRE](https://www.genecards.org/cgi-bin/carddisp.pl?gene=GABRE)
• [Human Protein Atlas: GABRE](https://www.proteinatlas.org/ENSG00000111640-GABRE)
• [ClinicalTrials.gov: GABRE](https://clinicaltrials.gov/search?cond=GABRE+epilepsy)
• [PubMed: GABRE Publications](https://pubmed.ncbi.nlm.nih.gov/?term=GABRE+GABA-A+receptor)